Table 2.
Rating construct | Definition and rating scales |
---|---|
Necessity of review |
For an average patient treated with antidepressants in primary care: Assuming no overprescribing/high-risk prescribing, how necessarya is it to conduct a critical review* of antidepressant use within the next 3 months in order to prevent adverse effects/reduce medication burden? 1–3 = not necessary; 4–6 = might be necessary; 7–9 = clearly necessary |
Likelihood of harm |
How likely is it that the patient will experience an adverse drug reaction if the clinical situation was to be continued for another year? 1–3 = unlikely; 4–6 = possible; 7–9 = probable |
Severity of harm |
If the patient experienced an adverse drug event as a result of antidepressant use, how severe would it be? 1–3 = minor; 4–6 = moderate; 7–9 = major |
aSee the “Methods” section for further detail regarding the definitions of a critical review and the rating construct of necessary